Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Karim Seif El Dahan, Darine Daher, Amit G. Singal

Clin Mol Hepatol. 2023;29(Suppl):S207-S219. Published online September 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0247

View: 9220 Download: 205 Web of Science: 15 Crossref: 18

Won Sohn, Yong-Han Paik

Clin Mol Hepatol. 2023;29(1):182-184. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0411

View: 3735 Download: 55 Web of Science: 1 Crossref: 1

Linda L. Wong, Ruel J. Reyes, Sandi A. Kwee, Brenda Y. Hernandez, Sumodh C. Kalathil, Naoky C. Tsai

Clin Mol Hepatol. 2017;23(3):239-248. Published online July 14, 2017

DOI: https://doi.org/10.3350/cmh.2017.0008

View: 9084 Download: 150 Web of Science: 34 Crossref: 36

1 |

Viewed By 10649	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7528	MAFLD: How is it different from NAFLD?
Viewed By 5426	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4871	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 4825	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Cited By 338	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 305	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 210	MAFLD: How is it different from NAFLD?
Cited By 104	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 104	Non-alcoholic fatty liver disease: Definition and subtypes

Search